Please login to the form below

Not currently logged in
Email:
Password:

top 10

This page shows the latest top 10 news and features for those working in and with pharma, biotech and healthcare.

ICR scientists create AI test to predict cancer drug combinations

ICR scientists create AI test to predict cancer drug combinations

Of the 128, the AI test correctly identified the top five ranked combinations 57% of the time, while it correctly identified the top 10 ranked combinations 83% of the time.

Latest news

More from news
Approximately 0 fully matching, plus 96 partially matching documents found.

Latest Intelligence

  • Is there such a thing as the new normal? Or is it simply the ‘here and now’? Is there such a thing as the new normal? Or is it simply the ‘here and now’?

    Most of the world’s Top 10 companies are tech businesses but pharma has only just opened the box of ‘digital transformation’ and now has to plug it in to become

  • The European Medicines Agency: PRIME’d for access? The European Medicines Agency: PRIME’d for access?

    n = 36. PRIME isn’t just for big companies: up to March 2018 just nine of the companies - with 10 PRIME treatments - are in the top 50 companies of 2017 by ... sales, and 6 are in the top 10 companies with Pfizer (with Spark Therapeutics), Novartis (by

  • The good, the bad and the ugly The good, the bad and the ugly

    The second half of the top 10 European companies is taken up by five companies that do not feature among the top 10 global pharma. ... The latter enjoyed a sales uplift of 16.3%, making it one of seven companies in the top 10 outfits to deliver strong

  • The tipping point The tipping point

    If we project forward to 2020, seven of the top 10 global medicines by spend will be biologics. ... If we take the top 20 biologics by spend, in two years, 15 of these will have biosimilars.

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    Two of the top 10 biopharma companies (GSK and AstraZeneca) have UK HQs and nearly 10% of the top 100 drugs available today originated from UK-based research. ... Moreover, it has been estimated that a further 10.0bn of funding is at risk by 2020.

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 11 fully matching, plus 57 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...